Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Rep. Waxman Supports Ban On Consumer Drug Ads

Posted by Chrissie Cole
Wednesday, December 10, 2008 12:06 AM EST
Category: Major Medical
Tags: FDA and Prescription Drugs, Rep. Henry Waxman, Consumer Ads, The Prescription Project, Drug Approvals

LEARN MORE

IMAGE SOURCE:© Wikimedia Commons / Rep. Henry Waxman / author: Tom

Rep. Henry Waxman (D-CA) is preparing to take the reins as Chairman of the Committee on Energy and Commerce, when new Congress convenes in January.

One of his top priorities, along with health-care issues, is to give regulators the authority to impose a two-year ban on consumer ads when a new drug first reaches the market and risks are not fully known.

“Drug companies vigorously market their products and engage in direct-to-consumer advertising during the first few years of approval. This in turn increases the amount of consumers exposed to safety risks long before they are fully understood, said Waxman in a conference sponsored by the watchdog group, The Prescription Project.

The goal of the Prescription Project, a known critic of industry marketing, is to avoid compromises in patient care resulting from conflicts of interest that erode public confidence in the medical profession.

In 2007, Waxman supported congressional efforts to allow the Food and Drug Administration (FDA) to ban television commercials for new drugs up to three years if officials deemed it necessary to protect the public health.

Following objections by some lawmakers that said it would infringe the constitutional protections of free speech, efforts failed. Congress, instead, granted the FDA the power to fine drug companies that run false or misleading promotions.

Television commercials by Drugmakers have often come under fire for downplaying associated side effects, over promising benefits and excessive prescribing.

Drug companies argue that the ads inform consumers about new treatments available that may benefit them. Voluntary guidelines adopted by drugmakers’ call for companies to withhold consumer advertising for “an appropriate period of time,” so they can first advise doctors about new medicines.

The California Democrat is also committed to the development and distribution of generic biotech drugs, a move that drug companies are likely to embrace and granting the FDA authority to regulate tobacco. #


No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes